12-56343467-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005419.4(STAT2):​c.2478G>T​(p.Gln826His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00891 in 1,614,160 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0090 ( 77 hom. )

Consequence

STAT2
NM_005419.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.339

Publications

22 publications found
Variant links:
Genes affected
STAT2 (HGNC:11363): (signal transducer and activator of transcription 2) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. In response to interferon (IFN), this protein forms a complex with STAT1 and IFN regulatory factor family protein p48 (ISGF3G), in which this protein acts as a transactivator, but lacks the ability to bind DNA directly. The protein mediates innate antiviral activity. Mutations in this gene result in Immunodeficiency 44. [provided by RefSeq, Aug 2020]
STAT2 Gene-Disease associations (from GenCC):
  • primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • pseudo-TORCH syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004781902).
BP6
Variant 12-56343467-C-A is Benign according to our data. Variant chr12-56343467-C-A is described in ClinVar as [Benign]. Clinvar id is 475692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00788 (1200/152292) while in subpopulation NFE AF = 0.0114 (774/68022). AF 95% confidence interval is 0.0107. There are 10 homozygotes in GnomAd4. There are 536 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT2NM_005419.4 linkc.2478G>T p.Gln826His missense_variant Exon 24 of 24 ENST00000314128.9 NP_005410.1 P52630-3R9QE65

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT2ENST00000314128.9 linkc.2478G>T p.Gln826His missense_variant Exon 24 of 24 1 NM_005419.4 ENSP00000315768.4 P52630-3

Frequencies

GnomAD3 genomes
AF:
0.00789
AC:
1201
AN:
152174
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00799
Gnomad ASJ
AF:
0.0378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00706
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0114
Gnomad OTH
AF:
0.00907
GnomAD2 exomes
AF:
0.00789
AC:
1985
AN:
251442
AF XY:
0.00790
show subpopulations
Gnomad AFR exome
AF:
0.00141
Gnomad AMR exome
AF:
0.00492
Gnomad ASJ exome
AF:
0.0361
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00693
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.00994
GnomAD4 exome
AF:
0.00902
AC:
13184
AN:
1461868
Hom.:
77
Cov.:
31
AF XY:
0.00906
AC XY:
6588
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00146
AC:
49
AN:
33480
American (AMR)
AF:
0.00528
AC:
236
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0345
AC:
901
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00208
AC:
179
AN:
86258
European-Finnish (FIN)
AF:
0.00790
AC:
422
AN:
53420
Middle Eastern (MID)
AF:
0.0210
AC:
121
AN:
5764
European-Non Finnish (NFE)
AF:
0.00957
AC:
10646
AN:
1111998
Other (OTH)
AF:
0.0104
AC:
630
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
714
1428
2142
2856
3570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00788
AC:
1200
AN:
152292
Hom.:
10
Cov.:
32
AF XY:
0.00720
AC XY:
536
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41556
American (AMR)
AF:
0.00798
AC:
122
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0378
AC:
131
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.00706
AC:
75
AN:
10620
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0114
AC:
774
AN:
68022
Other (OTH)
AF:
0.00898
AC:
19
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
44
Bravo
AF:
0.00721
TwinsUK
AF:
0.0102
AC:
38
ALSPAC
AF:
0.00727
AC:
28
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.0128
AC:
110
ExAC
AF:
0.00769
AC:
934
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0138
EpiControl
AF:
0.0128

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STAT2: PP2, BP4, BS1, BS2 -

Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

STAT2-related disorder Benign:1
Apr 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.17
T;.
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.66
T;T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
0.34
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.78
N;N
REVEL
Benign
0.082
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
0.0060
B;.
Vest4
0.14
MutPred
0.14
Gain of catalytic residue at N827 (P = 0.051);.;
MVP
0.35
MPC
0.40
ClinPred
0.0072
T
GERP RS
3.5
Varity_R
0.14
gMVP
0.24
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229363; hg19: chr12-56737251; API